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 INTRODUCTION 
Nosocomial infections are those acquired during hospital stay and 
not present or incubating in the patient during admission. Nosocomial 
infections increase both morbidity and mortality in critically ill patients. 
Many of these infections are preventable. Data suggest that 35% of 
nosocomial bloodstream infections, 22% of pneumonias, 33% of urinary 
tract infections can be prevented if hospitals have an effective infection 
control programme.1 
DEFINITION OF NOSOCOMIAL PNEUMONIA 
(CDC DEFINITION)2 
SIGNS AND SYMPTOMS 
at least 3 of the following:  
a) Fever (38.40C or 101.10F) or hypothermia (36.50C or 97.70F) with 
no other recognised cause 
b) Leukopenia (≤4000 WBC/mm3) or leukocytosis (≥15,000 
WBC/mm3)  
c) New onset of purulent sputum or change in character of sputum or 
increased respiratory secretions or increased suctioning 
requirements  
d) New onset or worsening cough or dyspnea, apnea, or tachypnea  
e) Rales or bronchial breath sounds  
f) Worsening gas exchange (eg, O2 desaturations [<94%], increased 
oxygen requirements, or increased ventilator demand) 
Chest radiographs with at least one of the following:  
a) New or progressive and persistent infiltrate  
b) Consolidation  
c) Cavitation  
d) Pneumatoceles, in infants <1 year old 
LABORATORY CRITERIA 
At least one of the following:  
a) Positive growth in blood culture
 
not related to another source of 
infection  
b) Positive growth in culture of pleural fluid  
c) Positive quantitative culture
 
from minimally contaminated lower 
respiratory tract specimen (eg, Bronchoalveolar lavage (BAL) or     
protected specimen brushing)  
d) >5% BAL-obtained cells contain intracellular bacteria on direct 
microscopic exam (eg, Gram stain)  
e) Histopathologic exam shows at least one of the following 
evidences of pneumonia:  
1. Abscess formation or foci of consolidation with intense 
polymorphonuclear accumulation in bronchioles and alveoli. 
2. Positive quantitative culture of lung parenchyma  
3. Evidence of lung parenchyma invasion by fungal hyphae or       
pseudohyphae 
The epidemiology and outcomes of ventilator-associated 
pneumonia are well described in adults, but few data exist for pediatric 
patients, particularly with respect to risk factors and outcomes such as 
attributable morbidity, mortality, and cost.  
Nosocomial pneumonia (NP) forms the second most common nosocomial 
infection in pediatric intensive care unit (PICU). A study from United 
States in 1999 showed that the most prevalent nosocomial infection was 
blood stream infection (41%), followed by pneumonia (23%), urinary 
tract infection (13%), skin and soft tissue (8%).3  
 The National Nosocomial Infection Surveillance (NNIS) program4 
sponsored by the Centers for Disease Control and Prevention collects 
information on nosocomial infections in several hundred hospitals of 
different sizes in United States (US). 
 Ventilator-associated pneumonia was the second most common 
cause of nosocomial infection in US, representing 20% of nosocomial 
infections in this population. 
A study of 20 PICUs in 8 countries performed by the European 
Multicenter Study Group5 found that the incidence of nosocomial 
infection was 23.6% and the most frequent nosocomial infection was 
pneumonia (53%). 
The Pediatric Prevention Network of the National Association of 
Children’s Hospitals and Related Institutions performed a cross-sectional 
observational study to determine the point prevalence of nosocomial 
infection, including bloodstream infections and ventilator-associated 
pneumonia on a single day in 35 PICUs in United States. In this study, the 
overall prevalence of nosocomial infection was 12%. Bloodstream 
infection was the most common nosocomial infection (41.3%), and 
ventilator-associated pneumonia was the second most common (22.7%).  
There are no such large scale studies from India. Many individual 
studies done show incidence between 27% to 35%6,7,8 
In ICU patients, nearly 90% of nosocomial pneumonias occur 
during mechanical ventilation. In mechanically ventilated patients, the 
incidence increases with duration of ventilation. The risk of ventilator 
associated pneumonia (VAP) is highest early in the course of hospital 
stay, and is estimated to be 3% / day during first 5 days of ventilation, 2% 
/ day during days 5 to 10 and 1% / day after this.9 
Early onset VAP or NP is defined as occurring within first 4 days 
of hospitalization. This usually carries a better prognosis, and is more 
likely to be caused by antibiotic sensitive bacteria. 
Late onset VAP or NP are those occurring 5 days or later of 
hospitalization. They are more likely to be caused by multidrug resistant 
organisms and associated with increased morbidity and mortaliity. 
ETIOLOGY 
NP is caused by a wide spectrum of bacterial pathogens. They may 
also be polymicrobial and are rarely due to viral and fungal pathogens in 
immunocompetent hosts10,11. Common pathogens include aerobic gram 
negative bacilli such as Escherichia coli, Klebsiella pneumoniae, 
Pseudomonas aeruginosa and acinetobacter species. Infections due to 
gram positive cocci such as Staphylococcus especially Methicillin 
resistant Staphylococcus aurues are rapidly emerging. Significant growth 
of oropharyngeal commensols like viridans group of streptococci, 
coagulase negative staphylococci, niesseria species and corynebacterium 
species can produce infection in immunocompromised hosts and some 
immunocompetent hosts12. 
PATHOGENESIS 
Colonisation of the buccal oropharyngeal mucosa and alteration of 
the endogenous microflora appear to be crucial antecedents to 
endotracheal colonisation and nosocomial pneumonia. Colonisation of 
upper airways is frequent in critically ill patients. It has been 
demonstrated that after 10 days in ICU, 86% of patients were colonized 
by gram negative bacilli and 70% with yeast13. Any patient who has been 
hospitalized likely to have altered endogenous pharyngeal microflora, 
associated with prolonged hospitalistion, serious underlying illness, 
recent antimicrobial therapy and immunosuppression14. Once the buccal 
oropharyngeal mucosa is colonized, the risk of lower respiratory tract 
colonisation is greater resulting in pneumonia. A study that examined the 
relative predictive value of positive surveillance cultures of upper airways 
in high risk patients found that 45% of the patients became colonized 
with aerobic gram negative bacilli by the end of first week. Lower airway 
colonisation is followed by infection with same organisms and preceded 
VAP in 2/3 of episodes15. 
The presence of an endotracheal tube provides a direct route for 
colonized bacteria to enter the lower respiratory tract. Upper airway and 
oral secretions can pool above the cuff of an endotracheal tube and line 
the tube, forming a biofilm. Starting as early as 12 hours after intubation, 
the biofilm contains large amounts of bacteria that can be disseminated 
into the lungs by ventilator-induced breaths. 16,17,18 In addition, the biofilm 
may become dislodged by instillation of saline into the endotracheal tube, 
suctioning, coughing, or repositioning of the endotracheal tube18. 
Endotracheal tubes cause an abnormal interruption between the upper 
airway and the trachea, bypassing the structures in the upper airway and 
providing bacteria a direct route into the lower airway16. Because the 
upper airway is bypassed, a decrease occurs in the body’s ability to filter 
and humidify air18.  
In addition, the cough reflex is often eliminated and/or decreased 
by the presence of an endotracheal tube19, and mucociliary clearance can 
be impaired because of mucosal injury during intubation20. An 
endotracheal tube provides a place for bacteria to bind in the trachea, a 
situation that further increases production and secretion of mucus20. The 
impairment of these natural host defense mechanisms increases the 
likelihood of bacterial colonisation and subsequent aspiration of the 
colonized organisms.  
The stomach-oral route may be a significant source of organisms 
colonizing the oropharynx22. Most patients receiving mechanical 
ventilation have a nasogastric or an orogastric tube in place for enteral 
feeding and administration of medications or for gastric decompression. 
The presence of a nasogastric or an orogastric tube interrupts the 
gastroesophageal sphincter, leading to increased gastrointestinal reflux 
and providing a route for bacteria to translocate to the oropharynx and 
colonize the upper airway. Enteral feedings increase both gastric pH and 
gastric volume, increasing the risk of both bacterial colonisation and 
aspiration21. However, tracheal colonisation precedes VAP in 93.5% 
cases versus gastric colonisation in only 13%.2 
Less common routes include inhalation of contaminated 
aerosolized fluids or medication and hematogenous seeding ( eg. Right 
sided bacterial endocarditis). 
There is an increased adherence of microorganisms to the epithelial 
cells of oropharyhx in ill patients24. Patients with chronic tracheostomies 
also exhibit greater tracheal cell adherence. Poor nutrition aggravates this 
condition25. Once the organisms gain entry to the lower respiratory tract, 
the normal defenses usually are sufficient to prevent infection. However 
under certain conditions, the functions of alveolar macrophages are 
disturbed. For example, patients with ARDS or preexisting pneumonia, 
secretion of cytokines like interleukin-1 increases26. The recruited 
granulocytes likewise function abnormally. Pulmonary edema impairs 
bacterial clearance from lung15,27. 
DIAGNOSIS 
The diagnosis of nosocomial pneumonia is suspected if the patient 
has a radiographic infiltrate that is new or progressive, along with clinical 
findings suggesting infection, which include new onset fever, purulent 
sputum, leukocytosis and decline in oxygenation. 
INVASIVE TECHNIQUES OF SAMPLING DISTAL AIRWAYS 
Fibre optic bronchoscopy allows direct selective access to the distal 
airways for sampling. However, there are a number of problems 
associated with the use of bronchoscopy; the expertise and equipment 
required is not always available and sampling is often followed by a 
period of hypoxaemia.28   
Two techniques are commonly used to obtain distal airway samples 
with the bronchoscope; Bronchoalveolar lavage (BAL) or protected 
specimen brushing (PSB).  
BRONCHOALVEOLAR LAVAGE 
BAL is performed by advancing the bronchoscope into a distal 
airway and instilling about 130–150 ml of sterile saline.29 Selection of the 
area of the lung for sampling is guided by the pattern of consolidation on 
the chest radiograph.  
As much of the saline as possible is aspirated and sent for 
quantitative culture. The most frequently used threshold for a positive 
culture is 104 colony forming units/ml.  
PROTECTED SPECIMEN BRUSH 
This technique was introduced in 1979 by Wiberley, et al in an 
attempt to reliably obtain lower respiratory tract specimens that are not 
contaminated with tracheal or tracheal tube organisms.30 This technique 
entails the advancement of a double lumen catheter system under direct 
vision into the desired distal airway. Once in position the brush is 
advanced expelling the carbowax plug at the distal end of the catheter. 
Brushings are taken and the brush is then retracted into the catheter and 
removed, thereby protecting the brush from contamination. The brush is 
suspended in 1 ml of saline and quantitative culture obtained. A threshold 
of 103 colony forming units/ml is used to signify a positive result.  
NON-BRONCHOSCOPIC SAMPLING OF DISTAL AIRWAYS 
BAL and PSB cannot both be performed without the aid of a 
bronchoscope. Non-bronchoscopic BAL is performed by blindly 
advancing a protected suction catheter through the tracheal tube until it 
becomes wedged in a distal airway. The inner cannula is then advanced  
past its protective sheath and 100 ml of saline introduced and aspirated. 
Non-bronchoscopic PSB is similarly performed by inserting a double 
lumen catheter through the tracheal tube until resistance is felt and then 
advancing the brush to obtain a specimen. The good concordance between 
microbiological data obtained by bronchoscopic and non-bronchoscopic 
techniques shows the diffuse nature of  parenchymal infection in those 
with VAP.31  
QUANTITATIVE CULTURES OF TRACHEAL ASPIRATES 
Collection of material for microbiological analysis using this 
technique is quick, simple, and widely available. While there is some 
evidence to suggest that the use of this method has a high false positive 
rate in the diagnosis of VAP, other studies suggest that quantitative 
analysis of tracheal aspirates offers a reliable alternative to invasive 
techniques.32,33,34. A threshold of    105 colony forming units/ml is used to 
distinguish tracheal colonisation from true VAP. 
Other tests include detection of elastin fibre,36,37 endotoxin,38 the 
triggering receptor expressed on myeloid cells (TREM-1)35  in respiratory 
secretions and detection of neutrophil CD64 expression in blood.39 
MANAGEMENT 
Aggressive and prompt treatment is required when nosocomial 
pneumonia is suspected in a critically ill patient. The initial empirical 
antibiotic therapy should be able to treat the organisms that are prevalent 
in PICU. For early onset pneumonia, β lactums like pencillin and 
cephalosporin are recommended. Vancomycin is considered if methicillin 
resistant Staph. aureus (MRSA)  is prevalent in the ICU. 
In late onset pneumonia, monotherapy will lead to risk of 
multidrug resistant bacterial growth. The American thoracic society40 
suggested a combination of at least two wide-spectrum antibiotics: 1) a β 
lactum (eg. ceftazidime, cefotaxime, imipenam or piperacillin) and 2) an 
aminoglycoside. Combined antibiotics like ticarcillin-clavunic acid or 
tazobactum-piperacillin also can be used instead of β lactums. 
Vancomycin is added if MRSA is prevalent. Antibiotics are changed after 
culture reports are available. Antibiotics are to be continued if 
nosocomial pneumonia is suspected by clinical and radiological evidence. 
PREVENTION 
Although VAP has multiple risk factors, many nursing 
interventions can reduce the incidence of this disease. Nurses are the first 
line of defense in preventing bacterial colonisation of the oropharynx and 
the gastrointestinal tract. Meticulous hand washing for 10 seconds should 
be performed before and after all contact with patients.41 In addition, 
gloves should be worn when contact with oral or endotracheal secretions 
is possible. Strategically placing a sign on a patient’s bed to remind 
health-care workers to wash their hands and wear gloves is an easy and 
cost-effective measure that can help minimize transmission of bacteria 
between patients. The use of protective gowns is not recommended as 
routine practice, but gowns should be used when antibiotic-resistant 
pathogens have been isolated and identified.41 
Bacterial colonisation of the stomach can lead to aspiration and 
colonisation of the respiratory tract. Most patients receiving mechanical 
ventilation are given stress ulcer prophylaxis, often with medications that 
increase the gastric pH. A study42 in the 1980s indicated that pathogens 
multiply in an alkaline gastric environment. In research43 conducted in a 
pediatric intensive care unit, VAP rates did not differ between patients 
receiving ranitidine, omeprazole, or sucralfate for stress ulcer 
prophylaxis. Nowadays, as the use of proton pump inhibitors for stress 
ulcer prophylaxis has increased, few studies have been conducted to 
address whether the incidence of VAP is affected by proton pump 
inhibitors. 
Mucus in the airways can become stagnant and serve as a medium 
for bacterial growth. Maintenance of aseptic technique when performing 
endotracheal suctioning is essential to prevent contamination of the 
airways. No difference has been found in the incidence of VAP with open 
versus closed suction systems.44 When a closed system is used, the 
suction catheter should be rinsed free of secretions away from the patient.  
Furthermore, saline lavage of endotracheal tubes before suctioning 
dislodges bacteria from the endotracheal tube into the lower airways, 
increasing the risk for VAP.45 Saline lavage has long been considered a 
means to liquefy secretions and prevent plugs of mucus in endotracheal 
tubes. However,  in one study,46 saline instillation did not thin secretions; 
rather it reduced the amount of oxygen that reached the lungs and 
increased blood pressure, heart rate, intracranial pressure, and the risk for 
VAP. Maintaining adequate hydration, ensuring proper humidification of 
the ventilatory circuit, and using nebulizer or mucolytic  agents can help 
decrease the viscosity of secretions and eliminate the need for saline 
lavage.45,46 Prophylactic use of systemic antibiotics does not decrease the 
incidence of VAP and when the agents are used inappropriately, antibiotic 
resistance can develop.47 
Routine turning of patients a minimum of every 2 hours can 
increase pulmonary drainage and decrease the risk for VAP. Use of beds 
capable of continuous lateral rotation can decrease the incidence of 
pneumonia but do not decrease mortality or duration of mechanical 
ventilation.48 These beds are costly and are not necessary for routine use 
in the prevention of VAP,41 although the use of speciality beds may be 
cost-effective and therapeutic for patients with poor oxygenation or 
impaired wound healing.  
Colonisation of the ventilator circuit can also play a role in the 
development of VAP. Daily changes of the ventilator circuit do not seem 
to decrease the incidence of VAP.49 The Centers for Disease Control and 
Prevention does not recommend changing the ventilator circuit more than 
once every 48 hours,41 and research50 has indicated that changing the 
ventilator circuit as infrequently as once a week does not increase the risk 
for VAP. It is recommended that the ventilator circuit be changed when 
visibly soiled.41 Many investigators have compared the impact of heat and 
moisture exchangers on the incidence of VAP with the impact of heated 
humidifiers. The results were inconclusive as to which form of humidity 
is associated with a higher incidence of VAP.  
In addition to strategies to prevent colonisation, strategies to 
prevent aspiration can also be used to decrease the risk for VAP. Because 
the presence of an endotracheal tube predisposes patients to VAP, patients 
should be assessed on a daily basis for potential weaning and extubation 
from mechanical ventilation. Several methods of assessing readiness for 
extubation exist. These include T-piece trials, weaning intermittent 
mandatory ventilation, and pressure-support ventilation.51  
Positioning patients in a semi-recumbent position with the head of 
the bed elevated 30° to 45° prevents reflux and aspiration of bacteria from 
the stomach into the airways. Simply elevating the head of the bed 30° 
can decrease VAP by 34%.52 Impaired gastric emptying can lead to                
over distention, or increased gastric residual volume, of the stomach and 
the potential for regurgitation and aspiration. Minimising the use of 
narcotic agents can help prevent aspiration of gastric and/or oral 
contents.19  
Decreasing use of narcotic and/or sedative agents in the intensive 
care unit must be done cautiously, because pain can limit deep breathing 
and impair oxygenation. Daily interruptions of continuous sedative 
infusions can shorten the duration of mechanical ventilation by more than 
2 days and length of stay in the intensive care unit by 3.5 days.53 
Monitoring gastric residual volumes and administering agents to increase 
gastric motility have been suggested as ways to prevent gastric 
overdistention.19 Although the effectiveness of these interventions in 
reducing VAP has not been tested in clinical trials, it is reasonable to 
avoid gastric over distention in an attempt to prevent aspiration.  
Because secretions tend to pool above the cuffs of endotracheal 
tubes, the oropharynx should be thoroughly suctioned to prevent 
aspiration of the pooled secretions before an endotracheal tube is 
replaced. Use of tubes with ports for continuous subglottic suctioning can 
decrease the incidence of VAP by 50%.54   
Studies are also being conducted with endotracheal tubes coated 
with silver nitrate. It is hypothesized that silver nitrate interferes with the 
ability of bacteria to line the endotracheal tube and form a biofilm. 
Further studies are needed to determine the cost-effectiveness of these 
coated tubes in preventing VAP.  
REVIEW OF LITERATURE 
Compared to the exhaustive data on adult nosocomial infections 
and nosocomial pneumonia(NP), there are very few studies on pediatric 
NP especially from developing countries. 
Patra P.K, et al 6 from Chandigarh did a prospective study in 
PICU of a multispeciality hospital. 72 children were included in the 
study. CDC criteria was used and infection was defined by a 
semiquantitative count of more than 105 cfu/mL of endotracheal aspirate. 
The incidence of NP in their study was 30.5%. .Acinetobacter 
anitratus was the most predominant isolate in 12 (54.5%), followed by 
Pseudomonas aeroginousa in 5 (22.7%), Klebsiella in 3 (13.6%) and 
E.coli in 1 (4.5%). Staphylococcus aureus (MRSA) was seen in one 
patient only. Ventilated patients who developed NP were compared with 
those who did not, with respect to age, sex, PRISM scores, nutritional 
status, duration and frequency of intubation (reintubation) and duration of 
mechanical ventilation, nasogastric feeding, sedation and use of H2 
blockers to identify risk factors for NP. Univariate analysis revealed that 
patients with NP had a significantly higher duration of mechanical 
ventilation and higher proportion and frequency of reintubation. On 
subjecting the significant variables to multiple logistic regression, 
reintubation was the only independent risk factor for development of NP. 
The percentage mortality in the group with NP and no NP was 31.8% and 
16% respectively. However this difference was not statistically 
significant. All the deaths in the group with NP were secondary to Gram 
negative infections with Pseudomonas contributing to 4 (57.1%) deaths 
followed by Klebsiella, E. coli and Acinetobacter in one patient each. 
Tullu MS, et al 7 from Mumbai did a prospective study for 6 
months in PICU to determine the incidence, risk factors, mortality and 
organisms causing nosocomial pneumonia  in intubated patients. In the 
study, 69 patients (49 males : 20 females) had an ET tube inserted. NP 
developed in 19 out of 59 patients with mechanical ventilation (MV) 
(32.20%; 8.92/100 days of MV; 3.65/100 patient-days). NP developed in 
19 out of the 69 patients with ET intubation (27.54%; 7.96/100 days of 
ET intubation). All these 19 patients had undergone mechanical 
ventilation. The organisms commonly isolated were E. coli (34.4%), 
Klebsiella (30.2%), Pseudomonas (11.5%), Proteus (11.5%), and 
Acinetobacter (5.2%). Other organisms isolated included 2 isolates each 
of Enterobacter and Citrobacter, and 1 isolate each of coagulase negative 
Staphylococci, Non-lactose fermentors and Salmonella. Age, sex, altered 
sensorium and immunocompromised status (including 3 HIV positive 
cases) did not increase the incidence of NP. MV for more than 48 hours 
and a PICU stay of more than 3 days significantly increased the incidence 
of NP. Mortality in patients with NP was 47.37% and those without NP 
were 45%. The difference was not statistically significant. 
Alexis M Elward, et al 55 from Washington did a prospective 
cohort study in the year 2000 to determine the rates, risk factors, and 
outcomes of ventilator-associated pneumonia in pediatric intensive care 
unit (PICU) patients. There were 34 episodes of ventilator-associated 
pneumonia in 30 patients of 911 admissions (3.3%) and 595 (5.1%) 
mechanically ventilated patients. The mean ventilator-associated 
pneumonia rate was 11.6/1000 ventilator days. The most common 
organisms isolated was Pseudomonas aeruginosa (29.4%). The other 
isolates were Klebsiella pneumoniae (14.7%), Staphylococcus aureus 
(11.8%), yeast (8.8%), Haemophilus influenza (8.8%), Streptococcus 
pneumoniae (5.9%). Multiple factors were analysed for risk factors. 
Ventilator-associated pneumonia was associated with the following 
procedures: reintubation, tracheostomy, transfusion, transport out of the 
PICU, the presence of a central line, multiple central venous catheters, 
bronchoscopy, thoracentesis, and burn debridement. The following 
medications were associated with ventilator-associated pneumonia: Total 
Parenteral Nutrition, steroids, and histamine type 2 receptor blockers. 
Patients with VAP had higher mean PRISM score and longer PICU and 
hospital stay.  
Only transfusion, reintubation, and transport out of the PICU 
remained significant in the forward stepwise logistic regression model. 
Patients with VAP had higher mortality rate (20% vs 7%) which 
approached statistical significance. 
A similar study was done by the same author in 1999 in 
Washington56. 322 intubated patients were included in study. There were 
18 episodes of VAP in 13 pts. The VAP rate was 10.39/1000 ventilator 
days. Increased VAP rates were associated with seizures , transplant , 
burns, congenital immmunodeficiency , respiratory arrest, 
cardiopulmonary arrest , transfusion, sepsis .Patients with VAP had 
higher admission Pediatric Risk of Mortality (PRISM) scores .Patients 
with VAP had longer hospital length of stay (LOS) , longer PICU LOS  
& were more likely to die. 
A prospective surveillance study was done by Almuneef M, et al57 
from Riyadh, Saudi Arabia to describe the rate, risk factors, and outcome 
of ventilator-associated pneumonia in pediatric patients. 361 eligible 
patients were enrolled. 37 developed VAP. The mean VAP rate was 8.87 
per 1,000 ventilation-days. Among VAP patients, Pseudomonas 
aeruginosa was the most common organism, followed by Staphylococcus 
aureus. Other gram-negative organisms were also encountered. There was 
no significant difference between VAP and non-VAP patients regarding 
mortality rate. Witnessed aspiration, reintubation, prior antibiotic therapy, 
continuous enteral feeding, and bronchoscopy were associated with VAP. 
On multiple logistic regression analysis, only prior antibiotic therapy, 
continuous enteral feeding, and bronchoscopy were independent 
predictors of VAP. 
Emad H. Ibrahim, et al 58 from Washington did a prospective 
cohort study identify the occurrence of ventilator-associated pneumonia  
in a community hospital, and to determine the risk factors for VAP and 
the influence of VAP on patient outcomes in a nonteaching institution. 
Eight hundred eighty patients received mechanical ventilation and 
comprised the study cohort. One hundred thirty-two patients (15.0%) who 
received mechanical ventilation acquired VAP during their ICU stay. 
Patients with VAP were also statistically more likely to require 
reintubation, tracheostomy, multiple central venous lines, and to receive 
treatment with histamine type-2 receptor antagonists or sucralfate  . 
Similarly, the durations of central vein catheterisation and mechanical 
ventilation were statistically longer among patients with VAP, 
Pseudomonas aeruginosa was the most common Gram-negative bacterial 
pathogen isolated from the respiratory tract among infected patients with 
VAP for both survivors and nonsurvivors. Staphylococcus aureus was the 
most common Gram-positive bacterial pathogen associated with VAP. 
The mortality rate of patients developing VAP (45.5%) was significantly 
greater than the mortality rate of patients without VAP (32.2%). Patients 
developing VAP had significantly longer lengths of stay in the ICU  
(23.9 days vs 5.9 days) and in the hospital (38.6 days vs 15.2 days), 
compared to patients without VAP. 
Many studies have been published which analysed individual risk 
factors for development of VAP. 
Yildizdas D, et al 43 from Turkey evaluated the effects of 
sucralfate, ranitidine, and omeprazole use on incidence of ventilator-
associated pneumonia (VAP) and mortality in ventilated pediatric critical 
care patients. Seventy patients (44%) developed VAP. VAP rate was 42% 
(16 of 38) in the sucralfate group, 48% (20 of 42) in the ranitidine group, 
45% (17 of 38) in the omeprazole group, and 41% (17 of 42) in the 
nontreated group. Overall mortality rate was 22% (35 of 160); it was 21% 
(8 of 38) in the sucralfate group, 23% (10 of 42) in the ranitidine group, 
21% (8 of 38) in the omeprazole group, and 21% (9 of 42) in the 
nontreated group. There was no difference in the incidence of VAP and 
mortality in mechanically ventilated PICU patients treated with 
ranitidine, omeprazole, or sucralfate, or nontreated subjects.  Nine 
patients (5.6%) had macroscopic bleeding. There was no statistically 
significant difference in macroscopic bleeding between groups. 
Torres, et al 59 from Spain did a case control study to confirm that 
reintubation can be a risk factor of nosocomial pneumonia in 
mechanically ventilated patients. Forty consecutive patients needing 
reintubation were selected as cases. Each case was paired with a matched 
control for the previous duration of mechanical ventilation (+/- 2 d). 
Nineteen (47%) of the cases developed pneumonia after reintubation 
compared with 4 (10%) of the controls. After adjusting for age, sex, and 
presence of prior bronchoscopy, the conditional logistic regression 
analysis demonstrated that reintubation was the only significant factor 
related to the development of pneumonia. Sixteen (73%) of the 22 patients 
lying semi recumbent during the interval between extubation and 
reintubation developed nosocomial pneumonia versus three (16%) of the 
18 in supine position. These results indicate that semirecumbency during 
the period between extubation and reintubation may play a role in 
nosocomial pneumonia development in patients who need reintubation. 
Total intensive care unit stay and crude mortality were also higher in 
reintubated patients when compared with controls. 
Jordi Valles, et al 60 did a randomised, controlled, blinded study to 
determine whether continuous subglottic aspiration prevents nosocomial 
pneumonia in mechanically ventilated patients. 76 patients were 
randomly allocated to receive continuous aspiration of subglottic 
secretions, and 77 control patients were allocated to receive usual care. 
The incidence rate of ventilator-associated pneumonia was 19.9 
episodes/1000 ventilator days in the patients receiving continuous 
aspiration of subglottic secretions and 39.6 episodes/1000 ventilator days 
in the control patients .This difference was due to a significant reduction 
in the number of gram-positive cocci and Haemophilus influenzae 
organisms in the patients receiving continuous aspiration. However, no 
differences were observed in the number of Pseudomonas aeruginosa or 
Enterobacteriaceae organisms. Episodes of ventilator-associated 
pneumonia occurred later in patients receiving continuous aspiration (12.0 
±7.1 days) than in the control patients (5.9 ±2.1 days) (P = 0.003). The 
microorganisms isolated from protected specimen brush or 
bronchoalveolar lavage cultures in patients with ventilator-associated 
pneumonia were same as previously isolated from cultures of subglottic 
secretions in 85% of cases. No significant differences in outcome were 
found.  
Mitra B Draculovic, et al 61 studied whether the incidence of 
nosocomial pneumonia can be reduced by  semi recumbent body position 
in intensive-care patients. 86 intubated and mechanically ventilated 
patients were randomly assigned to semi recumbent (n=39) or supine 
(n=47) body position. The frequency of clinically suspected nosocomial 
pneumonia was lower in the semi recumbent group than in the supine 
group (3 of 39 [8%] vs 16 of 47 [34%]). This was also true for 
microbiologically confirmed pneumonia (semi recumbent 2/39 [5%] vs 
supine 11/47 [23%]). Supine body position and enteral nutrition were 
independent risk factors for nosocomial pneumonia and the frequency 
was highest for patients receiving enteral nutrition in the supine body 
position (14/28, 50%). Mechanical ventilation for 7 days or more and a 
Glasgow coma scale score of less than 9 were additional risk factors. 
Bonten MJ, et al 62 analysed the role of enteral feeding in VAP in 
a randomised controlled trial in Netherlands. They studied the influence 
of intermittent enteral feeding [IEF] (18 h/d) and continuous enteral 
feeding [CEF] (24 h/d) on gastric and oropharyngeal colonisation. Sixty 
patients were randomised to receive either IEF or CEF, and continuous 
intragastric pH monitoring was performed in 50 patients. Median 
intragastric pH levels were similar before enteral feeding was instituted 
(pH 2.5 for CEF and pH 2.4 for IEF), and median pH values increased 
slightly after institution of nutrition (not significant). In patients receiving 
IEF, median pH decreased from 3.5 to 2.2 (p = 0.0002) when enteral 
feeding was discontinued. However, despite this, 80% of the patients in 
both study groups were colonized in the stomach after 7 days in study. In 
addition, colonisation rates of the oropharynx and trachea, the incidence 
of VAP, and mortality were similar in both study groups. They concluded 
that almost all patients receiving enteral feeding are colonized in the 
stomach with gram-negative bacteria which subsequently leads to VAP. 
Marin H. Kollef, et al 63 from Washington did a prospective 
cohort study to determine whether patient transport out of the ICU is 
associated with an increased risk of developing ventilator-associated 
pneumonia. A total of 273 (52.4%) mechanically ventilated patients 
required at least one transport out of the ICU while 248 (47.6%) patients 
did not undergo transport. Sixty-six (24.2%) of the transported patients 
developed ventilator-associated pneumonia compared with 11 (4.4%) 
patients in the group not undergoing transport (relative risk=5.5; 95% 
confidence interval [CI]=2.9 to 10.1; p<0.001). Multiple logistic 
regression analysis demonstrated that a preceding episode of transport out 
of the ICU was independently associated with the development of 
ventilator-associated pneumonia (adjusted odds ratio=3.8; 95% CI=2.6 to 
5.5; p<0.001). Other variables independently associated with the 
development of ventilator-associated pneumonia included reintubation, 
presence of a tracheostomy, administration of aerosols, and male gender. 
To evaluate the attributable morbidity and mortality of ventilator-
associated pneumonia (VAP) in intensive care unit (ICU) patients, Daren 
K Heyland, et al 64 from Canada conducted a prospective, matched 
cohort study. To determine the excess ICU stay and mortality attributable 
to VAP, they matched patients with VAP to patients who did not develop 
clinically suspected pneumonia. One hundred and seventy-seven patients 
developed VAP. As compared with matched patients who did not develop 
VAP, patients with VAP stayed in the ICU for 4.3 days (95% confidence 
interval [CI]: 1.5 to 7.0 d) longer and had a trend toward an increase in 
risk of death (absolute risk increase: 5.8%; 95% CI: 2.4 to 14.0 d; 
relative risk (RR) increase: 32.3%; 95% CI: 20.6 to 85.1%). They 
concluded that VAP prolongs ICU length of stay and may increase the 
risk of death in critically ill patients. 
Many studies were done to identify the best method for collection 
of respiratory tract secretions and analysis. Although lung biopsy is the 
best method, bronchoscopy is the best feasible option. However this is an 
invasive procedure. Many studies are done to identify the best non 
invasive method. 
The accuracy of quantitative culture and microscopic examination 
of lower respiratory tract secretions for the diagnosis of VAP was 
validated by Chastre, et al 65,66 who compared the results of 
quantitatively cultured lower respiratory tract secretions with those of 
culture and histopathologic examination of simultaneously obtained lung 
tissue. In the first study, quantitative culture of secretions obtained by 
protected specimen brush (PSB) was compared with histopathologic 
examination and quantitative culture of lung tissue. Of six patients with 
pneumonia confirmed by histologic criteria, all had at least one 
microorganism obtained at a concentration of >104 CFU/g of lung tissue. 
Compared with the results of histologic examination and quantitative 
culture of lung tissue, quantitative culture of secretions obtained by PSB 
using a diagnostic threshold of >103 Cfu/mL had a sensitivity of 100%, 
specificity of 60%, positive predictive value of 43%, and negative 
predictive value of 100%. 
In the second study, the results of protected specimen brush (PSB), 
bronchoalveolar lavage (BAL)  were compared with simultaneously 
obtained lung tissue . Patients were included in the study only if they had 
never had pneumonia or had acquired it during the terminal phase of their 
illness. Bronchoscopy was performed within 1 hour after death, while 
mechanical ventilation was continued and PSB and BAL samples were 
taken. Immediately after bronchoscopy, a left thoracotomy was 
performed, and lung tissue specimens were taken from the areas of lung 
where the bronchoscopic samples had been obtained. All but two patients 
had been receiving antibiotics before death, but antibiotic therapy had not 
been changed for >3 days. All lung segments judged to have moderate to 
severe pneumonia by histologic criteria yielded >104 cfu/g of tissue. PSB 
cultures (>103 cfu/mL) had a sensitivity of 82% and specificity of 89%. 
BAL cultures (>104 cfu/mL) had a sensitivity of 91% but a specificity of 
78%. 
Christian Brun-Buisson, et al 67 from France did a prospective 
observational study of 68 first episodes of suspected pneumonia in which 
specimens were obtained blindly (endotracheal aspirate [EA] and blinded 
protected telescoping catheter [PTC]) and via bronchoscopy (directed 
PTC bronchoscopy and BAL). Their adequacy was assessed using 
quantitative BAL fluid culture as the diagnostic standard. Their 
conclusions were as follows: Qualitative EA cultures have a high 
sensitivity but a high proportion (> 80%) of false-positive results when 
compared to BAL. Using simple semiquantitative cultures and a threshold 
corresponding to approximately 104cfu/mL markedly improved the 
diagnostic accuracy of EAsq relative to BAL and increased its specificity 
to 82%, while its sensitivity decreased to 77%. Protected samplings 
(blinded PTC and directed PTC) were associated with a similar sensitivity 
(77%) and an excellent specificity (97%) as compared with the 
nonprotected techniques, especially nonquantitative EA. They proposed 
that blinded samplings with quantitative (or possibly semiquantitative) 
culture may be an alternative tool for the routine management of 
suspected VAP, especially where and when bronchoscopy is not readily 
available. 
Rajasekhar T, et al 68 from Hyderabad studied the role of 
quantitative cultures of non-bronchoscopic samples such as blinded 
bronchial sampling (BBS) and endotracheal aspirates (ETA) in the 
management of ventilator associated pneumonia. The diagnostic 
thresholds for ETA and BBS were taken as 10 5 cfu/mL and 10 4 cfu/mL 
respectively. In a total of 15 patients suspected of VAP, 73.3% (11/15) 
cases tested positive for VAP. Quantitative culture results were positive 
for pathogenic organisms for VAP in which the colony counts were more 
than the diagnostic thresholds for ETA/BBS. 12 out of those 15 cases 
were subjected to both ETA and BBS quantitative cultures due to sample 
quality issues. In 10 out of 12 cases (83.3%) the ETA and BBS 
quantitative culture results were in total agreement detecting the same 
organism. The predominant organisms in the early-onset VAP group were 
Acinetobacter baumanii and Klebsiella spp. In the late onset group 
Pseudomonas aeruginosa was the most predominant. Reintubation and 
prior use of broad-spectrum antibiotics were found to be the two most 
significant risk factors associated with the development of VAP based on 
statistical analysis of risk factors. Other risk factors studied were hospital 
stay >2 days, surgery, nasogastric tube, tracheostomy, stress ulcer 
prophyaxis and IV sedation. None of those were found significant. 
Mauricio Ruiz, et al 69 from Spain studied the impact of 
noninvasive and invasive diagnostic approaches on outcome in a 
prospective, open, and randomised study in three intensive care units 
(ICUs) of a 1,000-bed tertiary care university hospital. Patients with 
suspected VAP were randomly assigned to noninvasive (Group 1) versus 
invasive (Group 2) investigation (tracheobronchial aspirates versus 
bronchoscopically retrieved protected specimen brush and 
bronchoalveolar lavage ). Samples were cultured quantitatively, and BAL 
fluid was examined for intracellular organisms (ICO) additionally. Initial 
empiric antimicrobial treatment was administered following the 
guidelines of the American Thoracic Society and adjusted according to 
culture results (and ICO counts in Group 2). Outcome variables included 
length of ICU stay and mechanical ventilation as well as mortality. 
Overall, 76 patients (39 noninvasive, 37 invasive) were investigated. VAP 
was microbiologically confirmed in 23 of 39 (59%) and 23 of 37 (62%)      
(p = 0.78). There were no differences with regard to the frequencies of 
community-acquired and potentially drug-resistant microorganisms. 
Antimicrobial treatment was changed in seven patients (18%) of Group 
1 and 10 patients (27%) of Group 2 because of etiologic findings 
(including five of 17 with ICO = 2% (p = not significant). Crude 30 day 
mortality was 31 of 76 (41%), and 18 of 39 (46%) in Group 1 and 14 of 
37 (38%) in Group 2 (p = 0.46). Adjusted mortality was 16% versus 11% 
(p = 0.53), and mortality of microbiologically confirmed pneumonia 10 of 
23 (44%) in both groups. Lengths of ICU stay and mechanical ventilation 
as well as mortality were not significantly influenced by diagnostic 
techniques. They concluded that noninvasive microbial investigation is to 
be used as the principal approach to microbial investigation in suspected 
VAP. 
STUDY JUSTIFICATION 
About 50% of patients admitted in Pediatric Intensive Care Unit 
(PICU) of Institute of Child Health (ICH) require ventilatory support. 
Many patients develop nosocomial pneumonia. The causative agents and 
risk factors vary in each PICU.  Nosocomial pneumonia increases 
morbidity and mortality in critically ill children. This increases the 
duration of stay, need for prolonged antibiotic administration and 
increased utilisation of hospital resources. 
Many studies on nosocomial pneumonia had been done in western 
countries. There has been limited data from developing countries 
especially India. There are no prior studies from our institute on 
nosocomial pneumonia. Hence it was decided to study the incidence, 
etiological agents, risk factors and outcome of nosocomial pneumonia in 
our PICU. The results of the study will be helpful in identifying potential 
risk factors and implementing preventive measures. The data on 
etiological agents will help in formulating antibiotic policy for 
nosocomial pneumonia. This can reduce irrational use of antibiotics and 
subsequently prevent colonisation of multidrug resistant organisms.  
AIM OF THE STUDY 
To study the 
• incidence,  
• etiological agents,  
• risk factors and  
• outcome  
of nosocomial pneumonia among ventilated children between 1 month 
and 12 years of age in pediatric intensive care unit. 
METHODOLOGY 
STUDY DESIGN: -     Cohort study 
STUDY PERIOD: -     Oct 2007 to Aug 2008 
STUDY PLACE: -       Pediatric Intensive Care Unit, Institute of Child 
Health and Hospital for Children. 
STUDY SUBJECTS:- 
Inclusion criteria: All children between 1 month and 12 years of                       
age intubated and ventilated in PICU during the study 
period.                    
Exclusion criteria:-   1) Children with preexisting pneumonia, 
                                  2) Children intubated for airway protection but not 
ventilated. 
GROUP 1 
Children with nosocomial pneumonia 
Case definition for nosocomial pneumonia among 
ventilated children. 
Pneumonia developing after 48 hours of endotracheal intubation 
and ventilation with,  
a) Fever (38.40C or 101.10F) with no other recognised cause  
b) Leukopenia (≤4000 WBC/mm3) or leukocytosis (≥15,000 
WBC/mm3)  
c) New onset of purulent sputum or change in character of sputum or 
increased respiratory secretions or increased suctioning 
requirements. 
d) Rales or bronchial breath sounds         and 
Chest radiographs with at least one of the following:  
       a) New infiltrate  
       b) Consolidation  
       c) Cavitation  
       d) Pneumatoceles, in infants <1 year old  and 
Semiquantitative culture of endotracheal aspirate positive for 
microorganisms (>105 colony forming units (cfu) / mL). 

GROUP 2   
Ventilated children who never developed pneumonia 
MANOEUVRE 
All patients fulfilling the inclusion criteria were enrolled in the 
study. Their demographic details like name, age, sex, address were 
collected. Data regarding their current illness and indication for PICU 
admission were noted. Parents were enquired about any premorbid 
conditions like chronic respiratory illness, cardiac diseases (congenital 
and acquired), neurological illness (cerebral palsy, neurodegenerative 
diseases). 
Indications for intubation were collected and classified into 
respiratory, cardiovascular and neurological conditions. 
Patients were followed up for occurrence of pneumonia. During 
follow up, duration of coma (Glasgow coma scale ≤ 8), duration of 
nasogastric feeding, duration of administration of H2 blockers were noted.  
The number of times a patient is reintubated was noted. 
Reintubations following accidental extubation, extubations following 
endotracheal tube block or displacement or reintubation following a 
planned extubation were recorded. 
Any patient developing pneumonia after 48 hours of intubation 
were considered as group 1. 
Pneumonia was diagnosed by the criteria mentioned above. Blood 
was drawn for complete blood count and blood culture. Endotracheal 
aspirate (ETA) was collected from such cases. 
Prior to endotracheal aspirate collection, the patient was 
preoxygenated with 100% oxygen. The heart rate and oxygen saturation 
were continuously monitored with a pulse oxymeter. The procedure was 
abandoned if saturation drops below 92%. 
Under strict aseptic precautions, the suction catheter was inserted 
beyond carina and secrections were collected in a sterile mucus trap. The 
secretions within mucus trap were sent to microbiology lab immediately 
for analysis. 
 In the laboratory 0.001 mL of sample was directly inoculated on 
the chocolate agar and Mc Conkey’s agar. Following overnight 
incubation at 37ºC, the media were examined for any growth. Infection 
was defined by a semi quantitative count of more than 100 cfu/ 0.001 mL, 
equivalent to 105 cfu/mL of ETA.The sensitivity pattern was studied by 
Disc Diffusion method. Isolation of microorganism with a cfu of 
<100/0.001 mL was defined as colonisation. 
The patients were followed up till 48 hrs of extubation or death. 
Ventilated children who improve without pneumonia on follow up 
were considered as group 2.  
The duration of ventilation, the duration of intubation (patients on 
T-piece ventilation) and duration of stay in PICU were recorded. The 
outcome was measured as death or recovery. 
Statistical analysis 
Data were collected in the proforma (Annexure 1). The categorical 
values were analysed using ‘chi-square test’ and relative risk was 
calculated. For continuous variables, mean of each variable in both 
groups were calculated and analysed using ‘student t test’. The variables 
found to be significant in both groups were subjected to multiple logistic 
regression analysis to adjust for confounding effect and to identify the 
independent risk factors. P value < 0.05 was considered as significant.   
OBSERVATIONS 
A total of 96 children, who fulfilled the inclusion criteria were 
included in the study. 35 of them developed nosocomial pneumonia 
(Group 1) and 61 children did not develop pneumonia (Group 2). 
pneumonia n=35
no pneumonia n=61
 
Fig 1. Incidence of nosocomial pneumonia among 
ventilated children. 
Out of 96 children studied, 35 (36.4%) developed nosocomial 
pneumonia. The incidence of nosocomial pneumonia among ventilated 
children in the study population was 36.4%. 
Among 35 children in group 1, 16 (45.7%) were less than 1 year, 
15 (42.9%) were between 1 and 5 years and 4 (11.4%) were between 6 
and 12 years. Among 61 children in group 2, 41 (67.2%) were less than 1 
year, 9 (14.8%) were between 1 and 5 years and 11 (18%) were between 
6 and 12 years. 
Table 1. Etiological organisms isolated in endotracheal aspirate 
ORGANISM n = 35 % 
Klebsiella 22 62.9% 
Staphylococcus aureus 5 14.3% 
E coli 3 8.6% 
Pseudomonas  3 8.6% 
Streptococci pneumoniae 2 5.7% 
 
The most common organism isolated was Klebsiella (22 cases; 
62.9%). Other isolates were Staphylococcus aureus (5 cases; 14.3%), E 
coli (3 cases; 8.6%), Pseudomonas (3 cases; 8.6%) and Streptococci 
pneumoniae ( 2 cases; 5.7%). Gram negative organisms were 
predominant among the isolates (80.1%). 
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        Fig 2. Etiological organisms isolated in endotracheal aspirate. 
Table 2: Risk factors for nosocomial pneumonia 
among ventilated children (univariate analysis) 
Risk factors Pneumonia 
n (%) 
No pneumonia 
n (%) 
RR 
(95% CI) 
P value
M 
Sex 
F 
19( 54.2) 
 
16 (45.7) 
18 (29.5) 
 
43 (70.4) 
 
1.9 (1.1-3.1) 
0.01 
Preexisting illnesses 
Y 
Resp 
N  
 
4 (11.4) 
 
31 (88.5) 
 
6 (9.8) 
 
55 (90.2) 
 
 
1.1 (0.3–3.8) 
 
 
0.80 
Y  
Cardiac 
N  
2 (5.7) 
 
33 (94.3) 
2 (3.3) 
 
59 (96.7) 
 
1.7 (0.2–11.8) 
 
0.56 
Y 4 (11.4) 8 (13.1)   
CNS 
N  
 
31 (88.6) 
 
53 (86.9) 
0.8 (0.2–2.6) 0.81 
Indication for 
intubation 
Y 
Resp 
N 
 
 
8 (22.9) 
 
27 (77.1) 
 
 
18 (29.5) 
 
43 (70.5) 
 
 
 
0.7 (0.3–1.5) 
 
 
 
0.48 
Y 
Cardiac 
N 
8 (22.9) 
 
27 (77.1) 
15 (24.6) 
 
46 (75.4) 
 
0.9 (0.4–1.9) 
 
0.84 
Y 
CNS 
N 
19 (54.3) 
 
16 (45.7) 
28 (45.9) 
 
33 (54.1) 
 
1.1 (0.7 – 1.7) 
 
0.42 
Y 
Bloodstream 
infection 
N 
14 (40) 
 
 
21 (60) 
22 (36) 
 
 
39 (64) 
 
1.1 (0.6 – 1.8) 
 
0.70 
P < 0.05 by chi-square test 
Among children who developed NP 19, (54.2%)  were male and 16 
(45.7%) were female. In children who did not develop pneumonia, 18 
(29.5%) were male and 43 (70.4%) were female. Males had 1.9 times 
more risk to develop NP than females.  [RR ( 95% CI ) = 1.9 (1.1 – 3.1) P 
= 0.01]. 
Pre existing respiratory, cardiac and neurological illnesses were not 
found to be significantly associated with NP. The current indication for 
intubation was studied in both groups and found to be not significant. 
Concurrent bloodstream infection was present in 14 children (40%) 
in pneumonia group and in 22 children (36%) in no pneumonia group 
showed evidence of bloodstream infection. There difference observed 
among both groups was not significant. 
Table 3 
Risk factors Pneumonia 
Mean ± SD 
No pneumonia 
Mean ± SD 
P value 
Age in months 27.94  ±  25.0 26.61  ±  33.3 0.83 
Reintubation  
(no. of times) 
 
1.46  ±  1.12 
 
0.41  ±  0.78 
 
0.00 
NG feeds  
 (no. of days) 
 
8.63  ± 3.62 
 
4.20  ±  4.36 
 
0.00 
H2 blockers (no. of days)  
5.09  ±  6.09 
 
4.13 ±  3.53 
 
0.95 
Low GCS (no. of days)   
7.83  ±  4.81 
 
5.48  ±  5.62 
 
0.04 
Duration of intubation      
(no. of days) 
 
13.0  ±  4.79 
 
 
7.15  ±  5.08 
 
0.00 
 
Duration of ventilation        
( no. of days) 
 
12.20  ±  5.09
 
6.79   ±  4.92 
 
0.00 
P <0.05 by student t test 
The mean age in children developing pneumonia was 27.94 ± 25 
months and those not developing pneumonia was 26.61 ± 33.3 months. 
There was no significant difference between two groups in terms of age.  
Reintubation occurred more frequently in pneumonia group  
(mean 1.46 ± 1.12 times) when compared to no pneumonia group  
(mean 0.41 ± 0.78 times). This difference was statistically significant  
(P = 0.00). 
Nasogastric tube feeding was given for a mean duration of 8.63  
± 3.62 days in pneumonia group and 4.20 ± 4.36 days in no pneumonia 
group. This difference was statistically significant and hence prolonged 
duration of nasogastric feeding was associated with developing 
pneumonia in ventilated children.  
The mean duration of administration of H2 blockers was 5.09  
± 6.09 days and 4.13 ± 3.53 days among pneumonia and no pneumonia 
groups respectively. This difference was not statistically significant. 
Children who developed pneumonia had Glasgow Coma Scale 
(GCS) ≤ 8 for 7.83 ± 4.81 days whereas those who did not develop 
pneumonia for 5.48± 5.62 days. There was statistically significant 
difference among both groups (P = 0.04) suggesting that GCS ≤ 8 is 
associated with developing pneumonia. 
The mean duration of ventilation and intubation was 12.2 ± 5.09 
days and 13 ± 4.79 days respectively in pneumonia group and 6.79 ± 4.92 
days and 7.15 ± 5.08 days respectively in no pneumonia group which was 
statistically significant (P = 0.00). Patients with NP had longer duration 
of ventilation and intubation. 
Table 4: Multivariate analysis of significant risk factors 
Risk factors OR (95% CI) P value 
Sex 2.27 (0.69 – 7.42) 0.17 
NG feeding 1.12 (0.83  –1.53) 0.43 
Low GCS 1.06 (0.87 – 1.31) 0.53 
Reintubation 0.31 (0.15 – 0.66) 0.02 
Duration of intubation 0.73 (0.35 – 1.51) 0.39 
Duration of ventilation 0.96 (0.49 – 1.87) 0.91 
 
The following risk factors were significantly associated with NP by 
univariate analysis: male sex, long duration of nasogastric feeding, 
prolonged duration of low GCS, increased frequency of reintubation, 
longer duration of intubation and ventilation. These factors were 
subjected to multivariate analysis. On multiple logistic regression 
analysis only reintubation was found to be significant risk factor for 
developing NP in ventilated patients. 
Outcome in patients with nosocomial pneumonia 
Table 5: Comparison of mortality among children 
with and without nosocomial pneumonia. 
 Pneumonia 
n (%) 
No pneumonia 
n (%) 
RR (95% CI) P value 
 
Death 
 
20 (57.1) 
 
19 (31.1) 
 
1.8 (1.1 – 2.9) 
 
0.01 
 
57.1% of children who developed NP died. But only 31.1% of 
children without NP died. This difference was statistically significant.                    
[RR ( 95% CI ) = 1.8 (1.1 – 2.9) P = 0.01). The risk for death was 1.8 
times higher for children who developed nosocomial pneumonia. 
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Fig 3. Comparison of outcome among two groups
Table 6: Comparison of duration of stay in PICU 
among the two groups 
 Pneumonia No pneumonia P value 
Duration of stay in PICU 
 (mean ± SD) days 
15.2  ± 5.5 9.6  ± 6.0 0.00 
 
Children who developed NP stayed in PICU for a mean of 15.2  
± 5.5 days whereas those who did not develop NP stayed for a mean of  
9.6 ± 6 days. Thus children with NP stayed a significantly (P = 0.00) 
longer duration in our PICU. 
Table 7: Early VS late onset pneumonia 
 n = 35 % 
Early onset pneumonia 19 54.3% 
Late onset pneumonia 16 45.7% 
 
Out of 35 children who developed pneumonia, 19 children (54.3%) 
had early onset pneumonia (≤ 4 days) and 16 children (45.7%) had late 
onset pneumonia (≥ 5 days). 
 
Table 8: Etiological organisms in early and late onset pneumonia 
ORGANISM EARLY ONSET 
PNEUMONIA 
n (%) 
LATE ONSET 
PNEUMONIA 
n (%) 
Klebsiella 13 (68.4) 9 (56.2) 
Staphylococcus aureus 2 (10.5) 3 (18.2) 
E coli 3 (15.7) 0 (0) 
Pseudomonas 0 (0) 3 (18.7) 
Streptococci 
pneumoniae 
1 (5.2) 1 (6.2) 
Total 19 16 
 
Klebsiella was the predominant organism isolated in both early 
onset (13 cases) and late onset pneumonia (9 cases). E coli was isolated 
only in early onset pneumonia. Similarly pseudomonas was isolated only 
in late onset pneumonia. The predominance of gram negative organisms 
was encountered in both groups. 
Table 9: Comparison of mortality among early and 
late onset pneumonia 
 Early onset 
pneumonia 
n (%) 
Late onset 
pneumonia 
n (%) 
 
RR (95% CI) 
 
P value
Died 8 (42.1) 12 (75.0) 0.5 (0.3 – 1.0) 0.05 
 
42.1% of children with early onset pneumonia died when compared 
to 75% of children with late onset pneumonia. This difference was 
however not statistically significant (P = 0.05).   
DISCUSSION 
The incidence of nosocomial pneumonia among ventilated children 
in this study population was 36.4%. This may not reflect the true 
incidence in the PICU as children with preexisting pneumonia were 
excluded in this study.  
Other Indian studies also had reported a similar higher incidence. 
Patra PK,et al6 from Chandigargh had quoted an incidence of 30.5%.   
Tullu MS,et al7 from Mumbai had reported an incidence of 27.54%.  
However studies from western countries reported a very lower incidence.  
In their study by Elward AM, et al55 from Washington, the 
incidence was just 5.1%. Almuneef, et al57 from Riyadh, Saudi Arabia 
found out an incidence of 10.2% in their PICU.  
Among the etiological organisms isolated, gram negative 
organisms were predominant. Klebsiella was the most predominant 
isolate in endotracheal aspirates, followed by Staphylococcus aureus, E 
coli. Pseudomonas and Streptococci pneumoniae. The microbiological 
flora associated with nosocomial pneumonia reflects the common 
organisms present in gut, oropharynx and environment. The colonisation 
of oropharynx by gram negative organisms from gut and then causing 
nosocomial pneumonia had been explained by Kervez AJ, et al13 and 
Atherton ST, et al22. 
In the study by Tullu MS, et al7, gram negative enterobacter 
organisms were predominant viz E coli in 34.4% and Klebsiella in 30.2%. 
Acinetobacter was the predominant isolate in the study by Patra PK, et 
al6.  This was not isolated in our study population. This may be also due 
to the difference in organisms prevalent in each ICU. 
Pseudomonas is mostly a nosocomial pathogen and this was 
isolated only in late onset pneumonia in this study. This correlates with 
the hypothesis that late onset pneumonia is usually acquired by 
nosocomial pathogens and early onset pneumonia by community acquired 
pathogens. In this study, Pseudomonas was isolated only in late onset 
pneumonia, concurring with the hypothesis. In contrary, Ibrahim, et al58 
in their study reported that this distinction did not hold true in an ICU 
setting and organisms in both groups were similar.  
Risk factors for nosocomial pneumonia in ventilated children. 
The mean age group was found to be similar in both pneumonia 
and no pneumonia groups. Age was studied as a risk factor by many 
authors but none found it as a risk factor6,7,55. Similarly age was not found 
to be a significant risk factor for nosocomial pneumonia in ventilated 
children in this study also. 
Males had 1.9 times increased risk than females for developing 
nosocomial pneumonia in this study. In this study, sex was a significant 
risk factor in univariate analysis but not in multivariate analysis. This 
might be probably due to unequal distribution of sex among both groups.  
Kollef, et al63 from Washington found that male gender is a 
significant risk factor in his study. But in studies by many others6,7,55, this 
was not a significant risk factor. 
 Previous respiratory and cardiac illnesses may lead to lower 
respiratory infections due to parenchymal changes or pulmonary 
congestion. Neurological illnesses may predispose to recurrent 
aspirations. But previous significant illnesses were not significantly 
associated with pneumonia in this study. In the study by Tullu MS, et al7, 
even immunodeficiency including HIV infection, was not associated with 
pneumonia. 
Also the various indications for intubation were not influencing the 
development of pneumonia. 
Co existing septicemia was noted only in 40%  of children with 
pneumonia and 36% of children without pneumonia.  
Thus the absence of association of previous illnesses and co 
existing sepsis with development of pneumonia, suggest that the 
pathophysiology of nosocomial pneumonia is predominantly aspiration of 
gastric and pharyngeal secretions. 
Reintubation was identified as the only significant independent risk 
factor for nosocomial pneumonia in multiple logistic regression analysis. 
During every attempt of intubation, there is a risk of aspiration of 
subglottic and oropharyngeal secretions. This predisposes to colonisation 
and subsequently infection of respiratory tract. 
A similar conclusion was made by Patra PK, et al6 from their study 
in Chandigarh. Reintubation and prolonged duration of ventilation was 
found to be significant risk factors in univariate analysis. Only 
reintubation was a significant risk factor in logistic regression analysis. 
Torres, et al59 had analysed separately the role of reintubation in 
nosocomial pneumonia. They found that reintubation was a significant 
risk factor after adjusting for age, sex and prio bronchoscopy. Studies by 
Ibrahim, et al58, Kollef, et al63 and Rajasekhar, et al68 had come up with 
similar results. 
Prolonged duration of nasogastric feeding was found to be a 
significant risk factor for nosocomial pneumonia in the present study. 
This may be probably due to increased chances of aspiration of gastric 
contents during enteral feeding. Bonten MJ, et al62 had found that there is 
slight increase in intragastric  pH during enteral feeding and this leads to 
colonisation of stomach with gram negative bacteria. Almuneef, et al57 
had found that continuous enteral feeding was an independent risk factor 
for developing nosocomial pneumonia.  Hence enteral feeds can also 
increase the risk of nosocomial pneumonia.  
H2 blockers increase the gastric pH and this was thought to 
promote colonisation of stomach with organisms. On aspiration, this may 
predispose to pneumonia. It has been observed in this study that H2 
blockers administration was not a significant risk factor for nosocomial 
pneumonia in ventilated children. Yildizdas, et al43 in their study found 
no difference in the incidence and mortality in patients developing 
ventilator associated pneumonia being treated with ranitidine, 
omeprazole, or sucralfate, and nontreated patients. Patra PK, et al6 also 
found that H2 blockers were not increasing the risk of nosocomial 
pneumonia in intubated children. But a study by Ibrahim, et al58 found a 
statistically significant association of H2 blockers with ventilator 
associated pneumonia. But the study subjects were adults whereas other 
two authors studied in pediatric population. Hence H2 blockers were not a 
significant risk factor for nosocomial pneumonia especially in pediatric 
population. 
Altered mental status with Glasgow Coma Scale (GCS) ≤ 8 was 
found to be a significant risk factor in this study. Draculovic, et al61 in 
their study found that GCS < 9 as a risk factor for nosocomial pneumonia. 
GCS ≤ 8 is a critically low GCS below which airway reflexes are 
impaired.  
George DL, et al70 had suggested that an altered mental status or 
depressed level of consciousness with impaired airway reflexes 
predisposes the patient to aspiration of gastric or oropharyngeal 
secretions leading to pneumonia. 
Longer the duration of intubation and ventilation, higher the risk of  
nosocomial pneumonia. This risk factor was significantly associated with 
pneumonia in studies by  Patra PK, et al6, Elward AM, et al55 and  
Tullu MS, et al7. 
On univariate analysis, risk factors viz. male sex, frequent 
reintubations, longer duration of nasogastric feeding, prolonged duration 
of low GCS, longer duration of intubation and ventilation were found to 
be significant. When adjusting for confounding effects of factors over 
each other, only reintubation was found to be significant. Patra PK, et al6 
study also found that duration of ventilation and reintubation were 
significant risk factors. But reintubation was the only independent risk 
factor. The study by Elward AM, et al55 analysed multiple risk factors but 
reintubation, transfusion and transport out of PICU were independent risk 
factors. The duration of ventilation was not an independent risk factor in 
many studies. This may be because aspiration could be the prime cause 
for development of pneumonia and it is commonly seen during 
reintubations. 
The patients with nosocomial pneumonia were higher risk of death 
and longer duration of stay in PICU than those who survived. Children 
with pneumonia were 1.8 times more likely to die than those who did not 
had nosocomial pneumonia following intubation. Heyland DK, et al64 
found that absolute risk of death increased by 5.8% in patients developing 
ventilator associated pneumonia.  
Among those who survived, the stay in PICU was significantly 
longer than who survived without pneumonia. This increases the burden 
on health care system by increasing health expenditure. 
SUMMARY 
The incidence of nosocomial pneumonia in this study was 36.4%. 
There was a predominance of gram negative organisms in endotracheal 
aspirates in our study. Klebsiella was the organism isolated in 62.9% 
cases. Pseudomonas was isolated only in late onset pneumonia cases. 
Age was not a significant risk factor for pneumonia in ventilated 
children. Males had 1.9 times higher risk of developing nosocomial 
pneumonia among ventilated children. Comorbid illnesses did not 
increase the risk of nosocomial pneumonia. Bloodstream infections did 
not influence the occurrence of pneumonia in ventilated children. 
Nasogastric feeding and GCS ≤ 8 were also risk factors for nosocomial 
pneumonia as they had the similar risk of aspiration. H2 blockers were not 
a significant risk factor for nosocomial pneumonia. Patients who 
developed pneumonia had a significantly longer duration of intubation 
and ventilation. Reintubation emerged as an independent risk factor for 
nosocomial pneumonia among ventilated patients. 
Mortality was higher in children who developed pneumonia and 
this difference was statistically significant. There was no significant 
difference in mortality in early and late onset pneumonia. The duration of 
stay in PICU was significantly longer in children developing nosocomial 
pneumonia following ventilation. 
CONCLUSION 
• The incidence of nosocomial pneumonia among ventilated children 
was 36.4% in the study population. 
• Gram negative bacteria especially Klebsiella was the predominant 
organism. 
• Reintubation was the most significant independent risk factor for 
developing nosocomial pneumonia in ventilated children. 
• Mortality was more than 50% in children with nosocomial 
pneumonia. 
• Reduction in the frequency of reintubation can reduce the 
incidence of  nosocomial pneumonia in intubated children. 
• Adequate sedation and analgesia can prevent accidental 
extubations and thereby reducing the need for reintubation. 
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ANNEXURE 
 
DATA ENTRY FORM 
Name 
Age 
Sex 
Address 
Date and time of admission in hospital 
Date and time of admission in PICU 
Date and time of endotracheal intubation 
Diagnosis 
Preexisting illness 
        Respiratory illness             yes/no 
        Heart disease                     yes/no 
        Neurological illnesses       yes/no 
Indication for intubation 
         Respiratory                        yes/no 
         Cardiac                              yes/no 
          CNS                                  yes/no 
On follow up 
 
                                                 DAYS OF FOLLOW UP 
 
 
Day of  intubation 
     
 
Reintubation 
     
 
NG feeding 
     
 
GCS ≤ 8 
     
 
H2 blockers 
     
 
Day of extubation 
     
 
Died on/ transferred out of PICU 
     
 
 
Blood stream infections           yes/no 
Pneumonia                                yes/no 
In patients developing pneumonia 
Day of onset of pneumonia 
Endotracheal aspirate                     Semiquantitative culture 
                                                        Antibiotic sensitivity 
Outcome 
Death                            
Recovery  
Duration of assisted ventilation 
Duration of endotracheal intubation 
Duration of stay in PICU 

 
